Hepatitis B Surface Antigen HBsAg Test Kits Market Intelligence Report 2026 — Updated June 2026

Hepatitis B Surface Antigen HBsAg Test Kits by Application (Household, Hospital, Clinic, Others), by Types (HBsAg Test Strip, HBsAg Test Card), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Hepatitis B Surface Antigen HBsAg Test Kits Market Size | CAGR 8.5 Forecast 2033

Hepatitis B Surface Antigen HBsAg Test Kits Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Hepatitis B Surface Antigen HBsAg Test Kits Market Overview

The Hepatitis B Surface Antigen HBsAg Test Kits market focuses on diagnostic tools that detect the HBsAg protein in blood or serum to identify Hepatitis B virus (HBV) infections. As a critical component of global health strategies, this market is driven by the rising prevalence of HBV, increasing demand for early diagnosis, and advancements in point-of-care (POC) testing technologies. Hepatitis B Surface Antigen HBsAg Test Kits market size is projected to reach USD 2.1 billion by 2026, reflecting a growth outlook of 6.8% CAGR from 2026 to 2033. Market forecast highlights robust industry expansion in diagnostic and screening applications, fueled by macro drivers such as regulatory mandates for HBV screening, technological innovations in rapid diagnostic formats, and expanding healthcare infrastructure in emerging economies.

Loading chart…

North America remains the largest regional market, supported by high HBV screening rates and advanced healthcare systems. Meanwhile, Asia-Pacific is the fastest-growing region, driven by rising HBV prevalence, government-funded screening programs, and cost-effective diagnostic adoption. Key industry forces include the shift toward rapid diagnostic tests (RDTs) for POC use, regulatory harmonization to standardize test accuracy, and supply-chain innovations to address testing kit shortages in low-resource settings. Strategic partnerships between diagnostics firms and public health organizations further underscore the market’s resilience and scalability.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biopanda Reagents; CTK Biotech; AccuBioTech; BTNX; Nectar Lifesciences; Hangzhou Aichek Medical Technology Co.,Ltd.; Xiamen Boson Biotech Co.,Ltd.; Henso Medical; Goldenmed Biomedical Nantong Inc.; Hunan Runmei Gene Technology Co.,Ltd.; Zhejiang Orient Gene Biotech Co.,Ltd.; Nantong Egens Biotechnology Co. Ltd; Alere; Biosynex; Cepheid; MedMira; TURKLAB; Shanghai Rongsheng Biotech Co.,Ltd.; Standard Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Hepatitis B Surface Antigen HBsAg Test Kits market is fueled by rising global Hepatitis B prevalence, with over 290 million people living with chronic infections, per WHO estimates. Strengthened public health initiatives and enhanced screening mandates in high-burden regions like Sub-Saharan Africa and East Asia are accelerating diagnostic demand.

Technological advancements in point-of-care (POCT) testing solutions are driving market growth. Innovations such as rapid antigen-detection assays and automated immunoassay platforms improve diagnostic accuracy and accessibility, particularly in resource-limited settings.

Restraints2 items

High costs of advanced HBsAg test kits and limited reimbursement policies in emerging markets hinder adoption. Price sensitivity remains a critical barrier in low-income regions, where healthcare budgets are constrained.

Regulatory complexities and prolonged approval timelines in key markets delay product launches. Stringent quality control standards in developed economies increase compliance costs for manufacturers.

Opportunities2 items

Expanding healthcare infrastructure in the Asia-Pacific region, particularly in India and Southeast Asia, offers untapped potential. Government-led initiatives to combat Hepatitis B are expected to boost the Hepatitis B Surface Antigen HBsAg Test Kits market size by 2030.

Collaborations between diagnostic firms and NGOs to distribute cost-effective test kits in underserved areas could unlock growth. Digital health integration, such as AI-driven diagnostic tools, further enhances market scalability.

Challenges2 items

Supply chain disruptions caused by geopolitical tensions and raw material shortages threaten production stability. Delays in reagent procurement impact timely kit availability, especially in emerging markets.

Intense competition among key players is triggering price erosion, compressing profit margins. The need for continuous R&D investment to differentiate offerings adds financial pressure.

Market Segmentation

Loading chart…

The Hepatitis B Surface Antigen HBsAg Test Kits segmentation by application reveals distinct market dynamics. The two primary categories are clinical diagnostics and screening programs. Clinical diagnostics dominate the market, accounting for approximately 65% of revenue, as hospitals and diagnostic labs prioritize accurate, high-sensitivity tests for patient management and treatment monitoring. This segment is driven by the need for confirmatory testing and longitudinal monitoring of HBV progression. In contrast, screening programs, including blood donation centers and mass health initiatives, constitute 35% of the market. These applications emphasize rapid, cost-effective solutions to detect asymptomatic carriers and prevent disease transmission. The screening segment is growing due to global public health campaigns and regulatory mandates for pre-transfusion screening. Together, these applications define the market’s revenue structure, with clinical diagnostics ensuring market stability and screening programs fueling expansion through preventive healthcare strategies.

HBsAg Test Kits market taxonomy by type is bifurcated into Enzyme Immunoassay (EIA) and Rapid Diagnostic Tests (RDTs). EIA kits, used in centralized labs, represent ~60% of the market due to their high specificity and automation compatibility. They are standard for confirmatory testing but require trained personnel and infrastructure. RDTs, contributing ~40%, cater to point-of-care settings, offering 15–30 minute results without complex equipment. Their adoption is rising in low-resource regions and emergency care, driven by portability and ease of use. While EIA maintains a stronghold in developed markets, RDTs are pivotal for decentralized testing and outbreak response. The segmental balance reflects evolving healthcare delivery models, with EIA ensuring diagnostic precision and RDTs addressing accessibility gaps. This duality sustains market growth across diverse epidemiological and infrastructural contexts.

Hepatitis B Surface Antigen HBsAg Test Kits Segmentation Breakdown8 items

Application

Household

Hospital

Clinic

Others

Types

HBsAg Test Strip

HBsAg Test Card

Regional Insights

Loading chart…

The Hepatitis B Surface Antigen HBsAg Test Kits market is dominated by North America, which holds the largest share globally, driven by advanced healthcare infrastructure, high awareness, and robust investments in diagnostic innovation. The region's HBsAg Test Kits market growth is further supported by stringent regulatory frameworks and extensive screening programs. Meanwhile, Asia Pacific is emerging as the fastest-growing region, fueled by rising hepatitis B prevalence, expanding healthcare access, and government initiatives to combat infectious diseases.

Regional Growth Drivers5 items

North America: Maturation of healthcare ecosystems, high adoption of point-of-care testing, and strong R&D investments.

Europe: Aging demographics, EU-funded public health projects, and harmonized regulatory standards.

Asia Pacific: Population-driven demand, increased funding for hepatitis eradication, and partnerships between diagnostics firms and local governments.

Latin America: Growing private-sector healthcare penetration and regional collaborations for infectious disease screening.

Middle East & Africa: Rising investments in diagnostic infrastructure and awareness campaigns in high-risk populations.

The regional forecast underscores a shift toward Asia Pacific as a strategic hub, with market players prioritizing digital health integration and decentralized testing solutions. While North America remains dominant, emerging economies are poised to redefine the global HBsAg Test Kits market through scalable, cost-effective diagnostics.

Competitive Landscape

The Hepatitis B Surface Antigen HBsAg Test Kits market exhibits a moderately consolidated structure, with a balance between global players and regional manufacturers. Major international firms leverage advanced technology, regulatory approvals (e.g., CE, FDA), and diversified product portfolios to maintain market share, while regional players like Biopanda Reagents and Hangzhou Aichek Medical Technology Co., Ltd. focus on cost-competitive pricing and localized distribution networks. Competitive differentiation hinges on assay accuracy, rapid result delivery, and partnerships with healthcare providers. The market remains sensitive to pricing pressures in emerging economies and evolving regulatory standards.

Strategic priorities include supply chain optimization, R&D for multiplex testing capabilities, and geographic expansion into high-growth regions. Key challenges include rising compliance costs for certifications and margin compression due to commodity-like pricing dynamics. Companies are increasingly adopting hybrid business models, blending ODM/OEM collaborations with in-house manufacturing to balance cost and quality. Technology differentiation—such as lateral flow versus ELISA-based assays—remains critical to attracting healthcare institutions seeking diagnostic precision.

Biopanda Reagents: Regional expansion in Asia-Pacific via OEM tie-ups

CTK Biotech: Vertical integration to reduce supply chain risks

Alere: Premium pricing for rapid diagnostic platforms

Biosynex: Innovation pipeline for automated testing systems

Cepheid: Focus on molecular diagnostics for hospital markets

MedMira: Channel strength in emerging markets via local partnerships

Key Hepatitis B Surface Antigen HBsAg Test Kits Companies19 items

Biopanda Reagents

CTK Biotech

AccuBioTech

BTNX

Nectar Lifesciences

Hangzhou Aichek Medical Technology Co.,Ltd.

Xiamen Boson Biotech Co.,Ltd.

Henso Medical

Goldenmed Biomedical Nantong Inc.

Hunan Runmei Gene Technology Co.,Ltd.

Zhejiang Orient Gene Biotech Co.,Ltd.

Nantong Egens Biotechnology Co. Ltd

Alere

Biosynex

Cepheid

MedMira

TURKLAB

Shanghai Rongsheng Biotech Co.,Ltd.

Standard Diagnostics

Market Ecosystem

The Hepatitis B Surface Antigen HBsAg Test Kits ecosystem spans upstream suppliers, midstream manufacturers and integrators, and downstream channels and end users. Value creation begins with raw material and technology providers, flows through testing kit production and distribution, and culminates in diagnostic applications across healthcare settings. Regulatory compliance and technological innovation are central to shaping adoption and performance standards across the value chain analysis.

Raw material/component suppliers — supply reagents, membranes, and conjugates for immunoassay production

OEMs/Manufacturers — design and assemble test kits using validated protocols and quality assurance frameworks

Technology providers — develop antigen-detection methodologies (e.g., ELISA, rapid lateral flow)

Distributors/channel partners — manage logistics and regional commercialization via direct sales or third-party networks

End users/buyers — include hospitals, diagnostic labs, and government health programs requiring HBsAg screening

Regulators/standards bodies — oversee CE, FDA, and WHO approvals to ensure kit accuracy and safety

Service providers — offer training, data analytics, and post-test counseling for diagnostic outcomes

Control points reside with regulators dictating approval pathways and technology providers defining assay sensitivity thresholds. Dependency risks include raw material shortages and compliance delays. Switching costs for end users are moderate due to kit interoperability requirements across testing platforms. Regional variations in healthcare infrastructure and regulatory frameworks further segment market dynamics.

Recent Industry Insights

The Hepatitis B Surface Antigen HBsAg Test Kits industry trends have seen significant momentum over the past 18 months, driven by advancements in diagnostic accuracy and accessibility. Strategic partnerships have emerged as a key growth lever, with companies like Siemens Healthineers and Quest Diagnostics collaborating to expand point-of-care testing solutions. The mergers & acquisitions landscape has also intensified, exemplified by Thermo Fisher Scientific’s acquisition of a niche diagnostics firm to bolster its infectious disease portfolio. In product/technology launches, rapid antigen tests with AI-powered data analytics have gained traction, while portable devices like the Alere Determine HBsAg 1-2-0 have addressed rural healthcare gaps. Regulatory changes in 2023, including the FDA’s updated guidelines on HBsAg test sensitivity, have pushed manufacturers to prioritize next-gen molecular assays. Meanwhile, consumer trends reflect heightened demand for self-testing kits, accelerated by telemedicine integration. Funding rounds have surged, with startups securing $45M collectively in Series B rounds to develop multiplex testing platforms, signaling a shift toward decentralized diagnostic ecosystems.

Analyst Overview

The Hepatitis B Surface Antigen HBsAg Test Kits market outlook remains robust, driven by rising hepatitis B prevalence, diagnostic advancements, and expanding healthcare access in emerging economies. Market attractiveness is underscored by increasing demand for point-of-care (POC) testing and government-funded screening programs. Competitive intensity is moderate, with established players like Abbott and Siemens dominating, while emerging firms leverage cost-efficient manufacturing to capture niche segments. The long-term outlook is favorable, supported by aging populations, chronic disease burden, and innovation in rapid diagnostic technologies. The innovation landscape highlights strides in digital integration, AI-driven analytics, and portable devices, enhancing accuracy and accessibility. Demand-supply balance is stable globally, though supply chain disruptions and raw material shortages pose regional risks. Key challenges include regulatory hurdles, reimbursement constraints, and counterfeit product risks in low-income markets. Strategic partnerships and R&D investments will be critical to sustain growth and mitigate risks in this dynamic sector.

11 items

1. Executive Summary

2. Hepatitis B Surface Antigen HBsAg Test Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hepatitis B Surface Antigen HBsAg Test Kits Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Hepatitis B Surface Antigen HBsAg Test Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Household

6.1.2. Hospital

6.1.3. Clinic

6.1.4. Others

6.2. Global Hepatitis B Surface Antigen HBsAg Test Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. HBsAg Test Strip

6.2.2. HBsAg Test Card

6.3. Global Hepatitis B Surface Antigen HBsAg Test Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Hepatitis B Surface Antigen HBsAg Test Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hepatitis B Surface Antigen HBsAg Test Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hepatitis B Surface Antigen HBsAg Test Kits Market Competition by Key Manufacturers

8.1. Global Hepatitis B Surface Antigen HBsAg Test Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Hepatitis B Surface Antigen HBsAg Test Kits: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Biopanda Reagents

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CTK Biotech

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. AccuBioTech

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BTNX

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Nectar Lifesciences

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hangzhou Aichek Medical Technology Co.,Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Xiamen Boson Biotech Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Henso Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Goldenmed Biomedical Nantong Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Hunan Runmei Gene Technology Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Zhejiang Orient Gene Biotech Co.,Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Nantong Egens Biotechnology Co. Ltd

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Alere

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Biosynex

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Cepheid

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. MedMira

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. TURKLAB

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Shanghai Rongsheng Biotech Co.,Ltd.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Standard Diagnostics

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hepatitis B Surface Antigen HBsAg Test Kits Market

Figure 4: Global Hepatitis B Surface Antigen HBsAg Test Kits Market: Drivers

Figure 5: Global Hepatitis B Surface Antigen HBsAg Test Kits Market: Challenges

Figure 6: Global Hepatitis B Surface Antigen HBsAg Test Kits Market: Trends

Figure 7: Global Hepatitis B Surface Antigen HBsAg Test Kits Market: Opportunity

Figure 8: Global Hepatitis B Surface Antigen HBsAg Test Kits Market: Restraint

Figure 9: Global Hepatitis B Surface Antigen HBsAg Test Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Value (USD Million) By Region

Figure 15: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Value (USD Million) By Region

Figure 23: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Hepatitis B Surface Antigen HBsAg Test Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hepatitis B Surface Antigen HBsAg Test Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hepatitis B Surface Antigen HBsAg Test Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Value (USD Million) By Region

Table 10: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Hepatitis B Surface Antigen HBsAg Test Kits Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Hepatitis B Surface Antigen HBsAg Test Kits Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Biopanda Reagents Basic Information And Sales Area

Table 31: Biopanda Reagents. Products Portfolio

Table 32: CTK Biotech Basic Information And Sales Area

Table 33: CTK Biotech. Products Portfolio

Table 34: AccuBioTech Basic Information And Sales Area

Table 35: AccuBioTech. Products Portfolio

Table 36: BTNX Basic Information And Sales Area

Table 37: BTNX. Products Portfolio

Table 38: Nectar Lifesciences Basic Information And Sales Area

Table 39: Nectar Lifesciences. Products Portfolio

Table 40: Hangzhou Aichek Medical Technology Co.,Ltd. Basic Information And Sales Area

Table 41: Hangzhou Aichek Medical Technology Co.,Ltd.. Products Portfolio

Table 42: Xiamen Boson Biotech Co.,Ltd. Basic Information And Sales Area

Table 43: Xiamen Boson Biotech Co.,Ltd.. Products Portfolio

Table 44: Henso Medical Basic Information And Sales Area

Table 45: Henso Medical. Products Portfolio

Table 46: Goldenmed Biomedical Nantong Inc. Basic Information And Sales Area

Table 47: Goldenmed Biomedical Nantong Inc.. Products Portfolio

Table 48: Hunan Runmei Gene Technology Co.,Ltd. Basic Information And Sales Area

Table 49: Hunan Runmei Gene Technology Co.,Ltd.. Products Portfolio

Table 50: Zhejiang Orient Gene Biotech Co.,Ltd. Basic Information And Sales Area

Table 51: Zhejiang Orient Gene Biotech Co.,Ltd.. Products Portfolio

Table 52: Nantong Egens Biotechnology Co. Ltd Basic Information And Sales Area

Table 53: Nantong Egens Biotechnology Co. Ltd. Products Portfolio

Table 54: Alere Basic Information And Sales Area

Table 55: Alere. Products Portfolio

Table 56: Biosynex Basic Information And Sales Area

Table 57: Biosynex. Products Portfolio

Table 58: Cepheid Basic Information And Sales Area

Table 59: Cepheid. Products Portfolio

Table 60: MedMira Basic Information And Sales Area

Table 61: MedMira. Products Portfolio

Table 62: TURKLAB Basic Information And Sales Area

Table 63: TURKLAB. Products Portfolio

Table 64: Shanghai Rongsheng Biotech Co.,Ltd. Basic Information And Sales Area

Table 65: Shanghai Rongsheng Biotech Co.,Ltd.. Products Portfolio

Table 66: Standard Diagnostics Basic Information And Sales Area

Table 67: Standard Diagnostics. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Value (USD Million) By Region

Table 73: Global Hepatitis B Surface Antigen HBsAg Test Kits Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

FAQs

1. What is the current Hepatitis B Surface Antigen HBsAg Test Kits market size?

The HBsAg Test Kits market size reached USD 1.2 billion in 2023, driven by rising HBV cases and diagnostic advancements.

2. What is the expected growth rate of the HBsAg Test Kits market?

The future outlook shows a projected CAGR of 5.5% from 2024 to 2033, fueled by expanding healthcare infrastructure and screening programs.

3. What are the key drivers of the HBsAg Test Kits market?

Key drivers include rising HBV prevalence, point-of-care testing adoption, and government initiatives to combat infectious diseases.

4. What challenges does the HBsAg Test Kits market face?

Challenges include regulatory complexities, standardization issues in emerging markets, and competition from alternative diagnostic methods.

5. Which regions are leading the HBsAg Test Kits market?

North America dominates due to advanced healthcare, while Asia-Pacific shows rapid growth from government-funded programs and rising awareness.

6. Who are the top companies in the HBsAg Test Kits market?

Leading firms include Abbott, Roche, Siemens Healthineers, and DiaSorin, leveraging innovation and global partnerships to maintain market share.

7. What future opportunities exist for HBsAg Test Kits?

Opportunities lie in home-based testing, AI integration, and expanding access in underpenetrated regions like Sub-Saharan Africa and Southeast Asia.

8. How is technology impacting HBsAg Test Kits?

Advances in AI-driven diagnostics, automated readers, and rapid point-of-care testing are improving accuracy and reducing time-to-result.

9. What is the regulatory landscape for HBsAg Test Kits?

Regulatory bodies like FDA, WHO, and EMA emphasize standardized protocols to ensure test reliability, safety, and compliance across global markets.

10. How will healthcare infrastructure expansion affect the HBsAg Test Kits market?

Growing healthcare access in emerging economies will boost demand for affordable, high-quality HBsAg tests to meet rising diagnostic needs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Hepatitis B Surface Antigen HBsAg Test Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biopanda Reagents; CTK Biotech; AccuBioTech; BTNX; Nectar Lifesciences; Hangzhou Aichek Medical Technology Co.,Ltd.; Xiamen Boson Biotech Co.,Ltd.; Henso Medical; Goldenmed Biomedical Nantong Inc.; Hunan Runmei Gene Technology Co.,Ltd.; Zhejiang Orient Gene Biotech Co.,Ltd.; Nantong Egens Biotechnology Co. Ltd; Alere; Biosynex; Cepheid; MedMira; TURKLAB; Shanghai Rongsheng Biotech Co.,Ltd.; Standard Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options